VIOPATCH

Delhi, India Founded: 1969 • Age: 57 yrs
Products are manufactured and marketed as topical and transdermal patches for pain relief.

About VIOPATCH

VIOPATCH is a Healthcare company based in Delhi (India) founded in 1969. Products are manufactured and marketed as topical and transdermal patches for pain relief. It operates in the Healthcare and Industrial Goods & Manufacturing sectors. The company has 19 employees. Its Indian entity Unexo Life Sciences Private Limited reported revenue of β‚Ή15.20 Cr. VIOPATCH offers products and services including Viopatch Pain Relief Patch and Viopatch XL. Its focus areas include Pharmaceuticals, Pain Management, Topical Patches and Manufacturing.

Company details

Viopatch is manufactured by Unexo Life Sciences Pvt. Ltd. as Indias first herbal pain relief patch, which is positioned as a safe alternative to oral painkillers and topical creams due to its side-effect-free nature. The products are distributed globally across more than 10 countries, with manufacturing based in Delhi, India, and compliance ensured through international GMP standards and regulatory approvals. In-house RD laboratories conduct necessary studies, and the patches are made available in various sizes for different pain conditions, emphasizing ease of use and effectiveness without reapplication needs. This approach is supported by clinical trials and patents that highlight its benefits in pain management.

  • Headquarters Delhi, India
  • Employees 19
  • Sectors
    Healthcare
    Industrial Goods & Manufacturing
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Social X Facebook Instagram
  • Legal Name Unexo Life Sciences Pvt. Ltd
  • Date of Incorporation 22 Oct, 2013
  • Jurisdiction Delhi, India
Key Metrics
  • Annual Revenue
    ₹15.20 Cr

    FY 2025 · -57% YoY

  • Net Loss
    -₹1.43 Cr

    FY 2025 · -9% margin

  • EBITDA
    ₹31.8 Lakh

    FY 2025 · 2% margin

  • Employee Count
    19

Products & Services of VIOPATCH

VIOPATCH offers a comprehensive portfolio of products and services, including Viopatch Pain Relief Patch and Viopatch XL.

Viopatch Pain Relief Patch
Pain Relief Products

The patch is utilized for herbal pain relief through transdermal delivery, where it is applied to various pain-affected areas.

Viopatch XL
Pain Relief Products

This extra large patch is employed for targeted relief of back pain, where it is designed for extended use on specific body areas.

Board of directors of Unexo Life Sciences Private Limited (VIOPATCH)

Unexo Life Sciences Private Limited is the primary company behind VIOPATCH. The board of Unexo Life Sciences Private Limited currently have 2 directors; the longest-serving is Saurabh Bansal, appointed in 2013. 1 earlier director has ceased.

DirectorDesignationAppointedTenureEntity
Saurabh Bansal
DIN 06694812
Director22 Oct 201313 yrsUnexo Life Sciences Private Limited
Suresh Kumar Bansal
DIN 00367166
Director01 Nov 202511 moUnexo Life Sciences Private Limited

Financials of VIOPATCH

Figures of Unexo Life Sciences Private Limited, the primary company behind VIOPATCH, for FY 2025. Revenue was ₹15.20 Cr (-57% year on year). Net loss was -₹1.43 Cr (-9% margin). EBITDA was ₹31.8 Lakh (2% margin). Revenue has grown at a compounded annual rate of -20% over three years and +5% over five years.

  • ₹15.20 CrRevenue · FY 2025 · -57% YoY
  • -₹1.43 CrNet loss · -9% margin
  • ₹31.8 LakhEBITDA · 2% margin
  • ₹25 LakhPaid-up capital
  • 19Employees (provident fund records)
  • -20%Revenue CAGR, 3 years
  • +5%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Unexo Life Sciences Private Limited are on its company page.

Premium access

Detailed financial statements for VIOPATCH

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Web traffic of VIOPATCH

The website of VIOPATCH (viopatch.in) receives about 1.1K visits a month.

  • Monthly visits
    1.1K

    ▲ 33.1% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Viopatch

Premium access

Complete news archive for VIOPATCH

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about VIOPATCH

VIOPATCH was founded in 1969.

VIOPATCH is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.

VIOPATCH has 19 employees.

The primary company behind VIOPATCH, Unexo Life Sciences Private Limited, reported revenue of β‚Ή15.20 Cr for FY 2025, down 57% year on year.

Viopatch is manufactured by Unexo Life Sciences Pvt. Ltd. as Indias first herbal pain relief patch, which is positioned as a safe alternative to oral painkillers and topical creams due to its side-effect-free nature. The products are distributed globally across more than 10 countries, with manufacturing based in Delhi, India, and compliance ensured through international GMP standards and regulatory approvals. In-house RD laboratories conduct necessary studies, and the patches are made available in various sizes for different pain conditions, emphasizing ease of use and effectiveness without reapplication needs. This approach is supported by clinical trials and patents that highlight its benefits in pain management.

VIOPATCH offers Viopatch Pain Relief Patch and Viopatch XL.

VIOPATCH operates through Unexo Life Sciences Private Limited.

The legal entities of VIOPATCH currently have 2 directors, including Saurabh Bansal, Suresh Kumar Bansal.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available